Human Rabies Survivors in India: An Emerging Paradox?

PLoS Neglected Tropical Diseases

Volumn 10, Issue 7, 2016, Pages

 

^a Mani), Reeta   (India)

Author keywords

[No Author keywords available]

Indexed keywords

RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ARTICLE; DEATH; DOG BITE; HEALTH CARE COST; HEALTH CARE FACILITY; HUMAN; POST EXPOSURE PROPHYLAXIS; PROFESSIONAL PRACTICE; RABIES; SOCIOECONOMICS; SURVIVOR; TREATMENT OUTCOME; VACCINATION; INDIA; MORTALITY; PATHOLOGY; SURVIVAL ANALYSIS;

HUMANS; INDIA; RABIES; RABIES VACCINES; SURVIVAL ANALYSIS;

EID: 84980325614     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004774     Document Type: Article

References (15)

1. World Health Organization. WHO Expert Consultation on Rabies: Second report. World Health Organization Technical Report Series 982, Geneva, WHO; 2013.
2. Sudarshan MK, Madhusudana SN, Mahendra BJ, Rao NS, Ashwath Narayana DH, Abdul Rahman S, et al. Assessing the burden of human rabies in India: results of a national multi-center epidemiological survey. Int J Infect Dis2007: 11: 29–35. 16678463
3. De Souza A, Madhusudana SN, Survival from rabies encephalitis. J Neurol Sci2014; 339(1–2): 8–14. doi: 10.1016/j.jns.2014.02.01324582283
4. Karande S, Muranjan M, Mani RS, Anand AM, Amoghimath R, Sankhe S, et al. Atypical rabies encephalitis in a six-year-old boy: clinical, radiological, and laboratory findings. Int J Infect Dis2015; 36: 1–3. doi: 10.1016/j.ijid.2015.05.00525975650
5. Kumar KV, Ahmad FM, Dutta V, Pituitary cachexia after rabies encephalitis. Neurol India2015; 63(2): 255–56. doi: 10.4103/0028-3886.15629525947994
6. Netravathi M, Udani V, Mani RS, Gadad V, Ashwini MA, Bhat M, et al. 2015: Unique clinical 402 and imaging findings in a first ever documented PCR positive rabies survival patient: A case report. J Clin Virol2015; 70: 83–88. doi: 10.1016/j.jcv.2015.07.00326305826
7. Rawat AK, Rao SK, Survival of a rabies patient. Indian Pediatr2011;48:574. 21813936
8. Mani RS, Anand AM, Madhusudana SN, Human Rabies in India: An Audit from a Rabies Diagnostic Laboratory. Trop Med Int Health. 2016; 21(4):556–63. doi: 10.1111/tmi.1266926799375
9. Madhusudana SN, Nagaraj D, Uday M, Ratnavalli E, Kumar MV, Partial recovery from rabies in a six-year-old girl. Int J Infect Dis. 2002; 6(1):85–6. 12118432
10. Hemachudha T, Ugolini G, Wacharapluesadee S, Sungkarat W, Shuangshoti S, Laothamatas J, Human rabies: neuropathogenesis, diagnosis, and management. Lancet Neurol. 2013; 12(5):498–513. doi: 10.1016/S1474-4422(13)70038-323602163
11. Willoughby RE, JrTieves KS, Hoffman GM, Ghanayem NS, Amlie-Lefond CM, Schwabe MJ, et al. Survival after treatment of rabies with induction of coma. N Engl J Med2005; 352:2508–2514. 15958806
12. Jackson AC, Jackson AC, Therapy of human rabies. In: Rabies-Scientific Basis of Disease and its Management (3rd edn). Academic Press: Oxford, 2013; 575–585.
13. Bakker AB, Python C, Kissling CJ, Pandya P, Marissen WE, Brink MF, et al. First administration to humans of a monoclonal antibody cocktail against rabies virus: safety, tolerability, and neutralizing activity. Vaccine. 2008; 26: 5922–5927doi: 10.1016/j.vaccine.2008.08.05018804136
14. De Benedictis P, Minola A, Rota Nodari E, Aiello R, Zecchin B, Salomoni A, et al. Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis. EMBO Mol Med. 2016; 8(4):407–21. doi: 10.15252/emmm.20150598626992832
15. Gogtay N, Thatte U, Kshirsagar N, Leav B, Molrine D, Cheslock P, et al. Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: a randomized, dose-escalation phase 1 study in adults. Vaccine. 2012; 26;30(50):7315–20. doi: 10.1016/j.vaccine.2012.09.02723010601